Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | GMAB | RGC | ||
| Company | Ascendis Pharma ADR | Genmab A/S ADR | Regencell Bioscience Holdings Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 238.51 | 27.81 | 25.91 | ||
| High | 240.77 | 27.81 | 25.91 | ||
| Low | 235.95 | 27.51 | 25.00 | ||
| Latest | 238.03 | 27.70 | 25.00 | ||
| Change | -3.35 | -0.48 | -0.45 | ||
| % Change | -1.39% | -1.70% | -1.77% | ||
| Volume | 117,768 | 184,016 | 10,312 | ||
| 20-Day Average Volume | 838,407 | 1,675,013 | 114,104 | ||
| Previous Close | 241.38 | 28.18 | 25.45 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 228.51 | 29.50 | 27.61 | ||
| 20-Day Raw Stochastic | 76.94% | 7.47% | 21.21% | ||
| 20-Day Relative Strength | 59.30 | 35.70 | 47.13 | ||
| Weighted Alpha | +64.01 | +12.57 | +59.55 | ||
| Today's Opinion | 100% Buy | 24% Sell | 40% Buy | ||
| Previous Opinion | 100% Buy | 8% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.78% since 02/26/26 | -5.68% since 02/26/26 | -4.57% since 02/26/26 | ||
| Low | 224.21 on 02/27/26 | 27.22 on 03/03/26 | 22.23 on 03/03/26 | ||
| High | 248.60 on 03/03/26 | 29.85 on 03/02/26 | 26.85 on 03/02/26 | ||
| 1-Month | |||||
| %Chg | +10.37% since 02/05/26 | -10.95% since 02/05/26 | +0.07% since 02/05/26 | ||
| Low | 211.00 on 02/12/26 | 27.22 on 03/03/26 | 22.23 on 03/03/26 | ||
| High | 248.60 on 03/03/26 | 31.41 on 02/17/26 | 35.70 on 02/13/26 | ||
| 3-Month | |||||
| %Chg | +16.79% since 12/05/25 | -13.11% since 12/05/25 | +54.48% since 12/05/25 | ||
| Low | 188.08 on 01/12/26 | 27.22 on 03/03/26 | 15.73 on 12/08/25 | ||
| High | 248.60 on 03/03/26 | 35.43 on 01/14/26 | 69.00 on 01/08/26 | ||
| 6-Month | |||||
| %Chg | +16.52% since 09/05/25 | +0.15% since 09/05/25 | +89.20% since 09/05/25 | ||
| Low | 186.05 on 10/20/25 | 27.14 on 09/08/25 | 10.33 on 11/25/25 | ||
| High | 248.60 on 03/03/26 | 35.43 on 01/14/26 | 69.00 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,960,009 | 18,102,380 | 12,584,746 | ||
| Shares Outstanding, K | 61,977 | 642,384 | 494,489 | ||
| Annual Sales | 814,760,000 | 3,720,000,000 | 0 | ||
| Annual Net Income | -258,000,000 | 963,000,000 | -3,580,000 | ||
| Last Quarter Sales | 279,270,000 | 1,058,000,000 | N/A | ||
| Last Quarter Net Income | -42,910,000 | 31,000,000 | N/A | ||
| 60-Month Beta | 0.43 | 0.94 | 2.08 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.17 on 11/12/25 | 0.65 on 11/06/25 | N/A | ||
| Latest Earnings Date | 05/07/26 | 05/14/26 | 01/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 02/15/18 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.85 | 0.00 | ||